Skip to main content
Premium Trial:

Request an Annual Quote

ABI, Affy, GE, NIAID Among Eight Groups to Act as ERCC RNAi Testing Sites

NEW YORK (GenomeWeb News) – The External RNA Controls Consortium today said that eight testing sites have registered for the initial phase of the RNA control testing initiative.
 
The participants are: Affymetrix, Agilent, Applied Biosystems, GE Healthcare, Illumina, National Institute of Allergy and Infectious Diseases, Qiagen, and Roche Molecular Systems.
 
The ERCC said it will be accepting applications for other non-manufacturing or non-production sites for control testing in different types of biological samples later this year.
 
Founded in 2003, the ERCC is an ad-hoc group with approximately 200 members from more than 65 private, public, and academic organizations that aims to develop a set of external RNA controls, related protocols, and analysis tools.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more